Alzheimer's disease trials recruiting in District of Columbia

All Alzheimer's disease trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
  NCT06976216 · Phase: Phase 3 · Ages: 60 Years to 85 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
  NCT06563895 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• DC Longitudinal Study on Aging and Specimen Bank
  NCT03702907 · Phase: Not specified · Ages: 45 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Late Onset Alzheimer's Disease
  NCT05010603 · Phase: Not specified · Ages: 55 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
  NCT06808984 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · District of Columbia: Washington D.C.